does semaglutide increase insulin sensitivity GLP-1 receptor agonism: a transformative approach for managing type-2 diabetes and obesity Is Ozempic® the Same as

its use rests on animal data and mechanistic reasoning

The same safety recommendations with name-brand GLP-1s apply to compounded versions

Subsequent research has reinforced these concerning findings, with a Danish nationwide cohort study of 424,152 type 2 diabetes patients demonstrating that semaglutide doubled the five-year NAION risk compared to other treatments

The common gastrointestinal side effects of GLP-1 receptor agonists - nausea, vomiting, diarrhea, constipation - are mediated by the drugs effects on the GI tract and brain, which should be the same regardless of whether the semaglutide or tirzepatide was produced by a commercial manufacturer or a compounding pharmacy